Gemcitabine - NDC Database (Page 5)

89 records found
Page:First PagePrevious Page5
70860-205 Jul 31, 2017
Gemcitabine 1 g/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Athenex Pharmaceutical Division, LLC.
71288-113 Nov 01, 2018
Gemcitabine 200 mg Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
71288-114 Nov 01, 2018
Gemcitabine 1 g/1 Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
71288-117 Dec 11, 2020
Gemcitabine 38 mg/ml Intravenous Injection, Solution by Meitheal Pharmaceuticals Inc.
72485-221 Jan 15, 2020
Gemcitabine 200 mg/5.26ml Intravenous Injection by Armas Pharmaceuticals Inc.
72485-222 Jan 15, 2020
Gemcitabine 1 g/26.3ml Intravenous Injection by Armas Pharmaceuticals Inc.
72485-223 Jan 15, 2020
Gemcitabine 2 g/52.6ml Intravenous Injection by Armas Pharmaceuticals Inc.
82511-008 Aug 08, 2024
Gemcitabine Hydrochloride 200 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Teyro Labs Private Limited
82511-009 Aug 08, 2024
Gemcitabine Hydrochloride 1 g/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Teyro Labs Private Limited
Page:First PagePrevious Page5
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.